Physician profile
Hani M Agrama
NPI 1285627380
$635.49
in general payments reported to CMS, 2019-2025
15 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $25.95 · 2021: $108 · 2022: $53.92 · 2023: $131 · 2024: $86.83 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $190.85 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $107.99 | 2020-2025 | Grafix Pl, Renasys Touch |
| Paratek Pharmaceuticals, INC. | $105.21 | 2023-2025 | Nuzyra |
| Convatec INC. | $34.12 | 2022 | |
| Kerecis Limited | $28.77 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Reprise Biomedical, INC. | $24.98 | 2025 | Miro3d |
| Lifenet Health | $23.00 | 2023 | |
| Solventum Corporation | $18.80 | 2024 | Activ.A.C. |
| Molnlycke Health Care US, LLC | $18.41 | 2023 | Mepilex Border Sacrum, Mextra Superabsorbant, Mepilex Border Flex |
| Mimedx Group, INC. | $15.29 | 2025 | |
| Ovik Health, LLC | $15.22 | 2023 | |
| Cashflow Solutions, LLC | $14.71 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Tactile Systems Technology INC | $13.95 | 2021 | |
| Reapplix INC. | $12.25 | 2021 | |
| Rgh Enterprises LLC | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Agrama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.